On July 26th the Crispr call trade ended in profit. The call options were sold for $0.65 each before fees. Some reasons for the trade are below. The original post on the trade can be found here. On to the next trade!
- Stop price hit.
- Other opportunities showing up
**
This blog is used for informational purposes only. It should not be
used as a recommendation to buy or sell any security. Do your own due
diligence before trading or investing. If you would like up to the
moment communication on KDK Options trades, email at
kdkoptions@gmail.com **
No comments:
Post a Comment